Merck(US:MRK) Xin Hua Cai Jing·2025-11-09 07:14Core Insights - Merck Animal Health showcased its integrated solutions for animal health at the 2025 China International Import Expo, emphasizing the "One Health" concept [2] - The company aims to enhance local R&D and production capabilities in China, with approximately 50 vaccines and chemical products already launched in the market [2] - The recent launch of two new vaccines for swine, aimed at addressing significant economic diseases in China's pig farming industry, is expected to improve herd health and farming efficiency [3] Group 1 - Merck Animal Health presented a comprehensive portfolio covering companion animals, aquaculture, pigs, poultry, and ruminants, integrating vaccines, pharmaceuticals, and technological solutions [2] - The company operates its China headquarters in Shanghai, with production bases in Ningbo and Tianjin, and a research center in Ningbo [2] - The newly approved vaccines, including the first needle-free intradermal vaccine for porcine circovirus, provide innovative solutions for common diseases affecting the swine industry [2][3] Group 2 - The introduction of the new vaccines is expected to help reduce the high costs associated with pig farming in China, which is the world's largest pork market [3] - The company believes that these solutions will contribute to the stability of pork supply and improve the quality of products available to consumers [3]